留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

海南省糖尿病相关慢性难愈性创面成年住院患者的流行病学特征

姚江凌 李佳璇 明星辰 顾运涛 姜涛 杨健 卞阳阳 郑林洋 王溶 曾允富 程少文

姚江凌, 李佳璇, 明星辰, 等. 海南省糖尿病相关慢性难愈性创面成年住院患者的流行病学特征[J]. 中华烧伤与创面修复杂志, 2026, 42(3): 1-9. DOI: 10.3760/cma.j.cn501225-20250606-00257.
引用本文: 姚江凌, 李佳璇, 明星辰, 等. 海南省糖尿病相关慢性难愈性创面成年住院患者的流行病学特征[J]. 中华烧伤与创面修复杂志, 2026, 42(3): 1-9. DOI: 10.3760/cma.j.cn501225-20250606-00257.
Yao Jiangling,Li Jiaxuan,Ming Xingchen,et al.Epidemiological characteristics of adult inpatients with diabetes-related chronic non-healing wounds in Hainan province[J].Chin J Burns Wounds,2026,42(3):1-9.DOI: 10.3760/cma.j.cn501225-20250606-00257.
Citation: Yao Jiangling,Li Jiaxuan,Ming Xingchen,et al.Epidemiological characteristics of adult inpatients with diabetes-related chronic non-healing wounds in Hainan province[J].Chin J Burns Wounds,2026,42(3):1-9.DOI: 10.3760/cma.j.cn501225-20250606-00257.

海南省糖尿病相关慢性难愈性创面成年住院患者的流行病学特征

doi: 10.3760/cma.j.cn501225-20250606-00257
基金项目: 

国家自然科学基金地区科学基金项目 82560446

海南省自然科学基金 822QN463, 822MS174

海南省重点研发计划项目 ZDYF2025SHFZ049

海南省科技卫生联合项目 WSJK2025QN076, WSJK2024QN013

海南医科大学大学生创新创业训练计划项目 S202511810040

详细信息
    通讯作者:

    程少文,Email:chengshaowen1@126.com

Epidemiological characteristics of adult inpatients with diabetes-related chronic non-healing wounds in Hainan province

Funds: 

Regional Science Foundation Project of National Natural Science Foundation of China 82560446

Hainan Provincial Natural Science Foundation 822QN463, 822MS174

Hainan Provincial Key R&D Program ZDYF2025SHFZ049

Hainan Provincial Science and Health Joint Project WSJK2025QN076, WSJK2024QN013

Hainan Medical University Undergraduate Innovation and Entrepreneurship Training Program S202511810040

More Information
  • 摘要:   目的  分析海南省糖尿病相关慢性难愈性创面成年住院患者的流行病学特征。  方法  该研究为回顾性队列研究。2019年7月—2024年7月,海南省3家医院收治1 372例符合入选标准的糖尿病相关慢性难愈性创面成年住院患者,其中海南医科大学第一附属医院收治951例、海南医科大学第二附属医院收治287例、海南省中德骨科医院收治134例。患者年龄18~96岁,其中男889例、女483例。收集患者以下病历资料,包括年龄、性别、职业,糖尿病分型、病程,合并基础疾病,创面形成原因、部位、类型、数量,创面分泌物标本病原微生物培养结果,创面治疗方式及转归情况,以及不同类型创面患者的住院时间、住院费用。  结果  患者以≥60岁、男性、农业从业者为主。98.91%(1 357/1 372)患者为2型糖尿病患者,糖尿病病程为10(5,18)年。糖尿病患者常合并高血压(678例)、动脉性疾病(300例)和脑卒中(220例)等。创面形成原因以感染为主;创面类型以糖尿病足溃疡(DFU)为主(809例),其次为其他创面(232例)、压力性损伤(187例)、创伤性溃疡(144例);创面主要位于足部及小腿,且主要为单发创面。540例患者创面分泌物标本病原微生物培养结果为阳性,共检出病原微生物606株,以革兰阴性菌(324株)为主,主要病原微生物为金黄色葡萄球菌(125株)、铜绿假单胞菌(71株)和大肠埃希菌(71株);真菌检出率[6.11%(37/1 372)]较高。治疗方式以单纯清创、清创+负压封闭引流为主。经治疗后,84.62%(1 161/1 372)患者创面好转,11.30%(155/1 372)患者创面愈合,3.28%(45/1 372)患者创面加重,0.80%(11/1 372)患者死亡。DFU患者住院时间[18(10,29)d]及住院费用[3.9(2.1,6.0)万元]均显著高于压力性损伤[14(7,21)d、2.8(1.5,4.2)万元]、创伤性溃疡[12(6,18)d、2.3(1.2,3.5)万元]及其他创面[16(8,25)d、3.1(1.8,5.0)万元],(P<0.05)。  结论  海南省糖尿病相关慢性难愈性创面成年住院患者以老年男性农业从业者为主,通常合并基础疾病,创面检出病原微生物以革兰阴性菌为主,真菌检出率较高。DFU治疗负担最重,DFU患者住院时间及住院费用均显著高于其他创面患者。

     

  • 参考文献(38)

    [1] NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants[J].Lancet,2024,404(10467):2077-2093.DOI: 10.1016/S0140-6736(24)02317-1.
    [2] ChengB,JiangY,FuX,et al.Epidemiological characteristics and clinical analyses of chronic cutaneous wounds of inpatients in China: prevention and control[J].Wound Repair Regen,2020,28(5):623-630.DOI: 10.1111/wrr.12825.
    [3] 郑林洋,姚江凌,卞阳阳,等.热带地区慢性难愈性创面流行病学调查[J].创伤外科杂志,2020,22(5):359-362.DOI: 10.3969/j.issn.1009-4237.2020.05.009.
    [4] LiY,TengD,ShiX,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J].BMJ,2020,369:m997.DOI: 10.1136/bmj.m997.
    [5] McDermottK,FangM,BoultonA,et al.Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers[J].Diabetes Care,2023,46(1):209-221.DOI: 10.2337/dci22-0043.
    [6] WangX, QueH. Diagnostic Significance of Serum VEGF, bFGF, and Wound Tissue EGFR in diabetic chronic refractory wounds[J]. Int J Low Extrem Wounds, 2025:15347346241313010. DOI: 10.1177/15347346241313010.
    [7] Roldán-MarínR,Contreras-RuizJ,ArenasR,et al.Fixed sporotrichosis as a cause of a chronic ulcer on the knee[J].Int Wound J,2009,6(1):63-66.DOI: 10.1111/j.1742-481X.2008.00565.x.
    [8] AlamW,HassonJ,ReedM.Clinical approach to chronic wound management in older adults[J].J Am Geriatr Soc,2021,69(8):2327-2334.DOI: 10.1111/jgs.17177.
    [9] RaiV,MoellmerR,AgrawalDK.Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer[J].Mol Biol Rep,2023,50(2):1913-1929.DOI: 10.1007/s11033-022-08107-4.
    [10] DongJ,ChenL,ZhangY,et al.Mast cells in diabetes and diabetic wound healing[J].Adv Ther,2020,37(11):4519-4537.DOI: 10.1007/s12325-020-01499-4.
    [11] Sandoval-SchaeferT,PhanQ,DashBC,et al.Transcriptional heterogeneity in human diabetic foot wounds[J].bioRxiv,2023:2023.02.16.528839.DOI: 10.1101/2023.02.16.528839.
    [12] YangH,ZhangX,XueB.New insights into the role of cellular senescence and chronic wounds[J].Front Endocrinol (Lausanne),2024,15:1400462.DOI: 10.3389/fendo.2024.1400462.
    [13] DhallS,AlamatR,CastroA,et al.Tobacco toxins deposited on surfaces (third hand smoke) impair wound healing[J].Clin Sci (Lond),2016,130(14):1269-1284.DOI: 10.1042/CS20160236.
    [14] TabanjehSF,Al-MalkiT,KharabshehRA,et al.A case series of autologous platelet-rich plasma injection in treating chronic ulcers conducted in Saudi Arabia[J].Int J Health Sci (Qassim),2023,17(2):46-56.
    [15] 李赞,刘喜洋,贺卓佳,等.1999-2019年中国糖尿病疾病负担的调查研究[J].解放军医学杂志,2024,49(7):776-782.DOI: 10.11855/j.issn.0577-7402.0602.2024.0516.
    [16] WolnyD,ŠtěpánekL,HorákováD,et al.Risk factors for non-healing wounds-a single-centre study[J].J Clin Med,2024,13(4):1003.DOI: 10.3390/jcm13041003.
    [17] 赵雅玫,冯磊,谢斌,等.抗生素骨水泥治疗糖尿病足溃疡疗效的Meta分析[J].中华糖尿病杂志,2024,16(7):790-798.DOI: 10.3760/cma.j.cn115791-20230927-00201.
    [18] GohilK.An overview of diabetes-related foot ulcers[J].Br J Community Nurs,2024,29(Sup6):S30-S36.DOI: 10.12968/bjcn.2024.29.Sup6.S30.
    [19] EijazS,LalpuriaS,AfzalM,et al.Prevalence of complications associated with diabetes among Pakistani patients: a questionnaire-based survey[J].Curr Diabetes Rev,2022,18(9):e190122200353.DOI: 10.2174/1573399818666220119100629.
    [20] MakilingM,SmartH.Patient-centered health education intervention to empower preventive diabetic foot self-care[J].Adv Skin Wound Care,2020,33(7):360-365.DOI: 10.1097/01.ASW.0000666896.46860.d7.
    [21] BahadoranZ,MirmiranP,HosseinpanahF,et al.Nitric oxide-based treatments improve wound healing associated with diabetes mellitus[J].Med Gas Res,2025,15(1):23-35.DOI: 10.4103/mgr.MEDGASRES-D-24-00020.
    [22] MedinaLopez AI,FregosoDR,GallegosA,et al.Beta adrenergic receptor antagonist can modify Pseudomonas aeruginosa biofilm formation in vitro: implications for chronic wounds[J].FASEB J,2022,36(3):e22057.DOI: 10.1096/fj.202100717RR.
    [23] SharmaAD,JarmanEH,KuppalliK,et al.Successful topical treatment of human biofilms using multiple antibiotic elution from a collagen-rich hydrogel[J].Sci Rep,2024,14(1):5621.DOI: 10.1038/s41598-024-54477-z.
    [24] 羊奕杰,仲海燕,崔磊,等.逆行足底内侧皮瓣修复前足底创面后感觉运动功能恢复的远期随访研究[J].组织工程与重建外科杂志,2025,21(4):331-336.DOI: 10.3969/j.issn.1673-0364.2025.04.001.
    [25] YaoJ,ZengY,YangJ, et al. Repairing tendon-exposed wounds bycombing the Masquelet technique with dermoplasty[J].Front.Surg, 2022, 9:995316.DOI: 10.3389/fsurg.2022.995316.
    [26] DinhN,de GraaffB,CampbellJA,et al.Costs of major complications in people with and without diabetes in Tasmania, Australia[J].Aust Health Rev,2022,46(6):667-678.DOI: 10.1071/AH22180.
    [27] DinhN,de GraaffB,CampbellJA,et al.Risk of hospital admission or emergency department presentation due to diabetes complications: a retrospective cohort study in Tasmania, Australia[J].Aust Health Rev,2023,47(3):282-290.DOI: 10.1071/AH22271.
    [28] JozicI,AbujamraBA,ElliottMH,et al.Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds[J].Commun Biol,2021,4(1):757.DOI: 10.1038/s42003-021-02298-5.
    [29] FranzS,TorregrossaM,AndereggU,et al.Dysregulated S100A9 expression impairs matrix deposition in chronic wounds[J].Int J Mol Sci,2024,25(18):9980.DOI: 10.3390/ijms25189980.
    [30] KurkipuroJ,MierauI,WirthT,et al.Four in one-combination therapy using live Lactococcus lactis expressing three therapeutic proteins for the treatment of chronic non-healing wounds[J].PLoS One,2022,17(2):e0264775.DOI: 10.1371/journal.pone.0264775.
    [31] LauterbachAL,SlezakAJ,WangR,et al.Mannose-decorated co-polymer facilitates controlled release of butyrate to accelerate chronic wound healing[J].Adv Healthc Mater,2023,12(26):e2300515.DOI: 10.1002/adhm.202300515.
    [32] KohK,WangJK,ChenJ,et al.Squid suckerin-spider silk fusion protein hydrogel for delivery of mesenchymal stem cell secretome to chronic wounds[J].Adv Healthc Mater,2023,12(1):e2201900.DOI: 10.1002/adhm.202201900.
    [33] 吕大伦,徐姝娟,丁伟,等. 慢性难愈合创面病原微生物分布及其耐药性分析[J]. 中华烧伤杂志,2015,31(4):290-292. DOI: 10.3760/cma.j.issn.1009-2587.2015.04.014.
    [34] LiX, QiX, YuanG, et al. Microbiological profile and clinical characteristics of diabetic foot infection in northern China: a retrospective multicentre survey in the Beijing area[J]. J Med Microbiol, 2018, 67(2):160-168. DOI: 10.1099/jmm.0.000658.
    [35] ZhangF,YangC,LiM,et al.Characterization of microbial profiles and antimicrobial resistance in diabetic foot ulcers at a tertiary care facility in northern China[J].Diabetes Ther,2025,16(10):1899-1915.DOI: 10.1007/s13300-025-01778-9.
    [36] Da PortoA,MirandaC,BrosoloG,et al.Nutritional supplementation on wound healing in diabetic foot: What is known and what is new?[J].World J Diabetes,2022,13(11):940-948.DOI: 10.4239/wjd.v13.i11.940.
    [37] TangYB,UwimanaM,ZhuSQ,et al.Non-coding RNAs: role in diabetic foot and wound healing[J].World J Diabetes,2022,13(12):1001-1013.DOI: 10.4239/wjd.v13.i12.1001.
    [38] RenH, SuP, ZhaoF, et al. Adipose mesenchymal stem cell-derived exosomes promote skin wound healing in diabetic mice by regulating epidermal autophagy[J/OL]. Burns Trauma, 2024, 12: tkae001[2025-06-06]. https://pubmed.ncbi.nlm.nih.gov/38434722/. DOI: 10.1093/burnst/tkae001.
  • Table  1.   1 372例糖尿病相关慢性难愈性创面成年住院患者的基本资料

    特征例数比例(%)
    年龄
    18~<45岁815.90
    45~59岁39929.08
    ≥60岁89265.01
    性别
    88964.80
    48335.20
    职业
    农业从业者83861.08
    职员24017.49
    自由职业者18013.12
    无业人员574.15
    不详574.15
    不良生活习惯
    仅吸烟18113.19
    仅饮酒13810.06
    吸烟+饮酒946.85
    下载: 导出CSV

    Table  2.   1 372例糖尿病相关慢性难愈性创面成年住院患者合并基础疾病情况

    基础疾病例数比例(%)
    高血压67849.42
    动脉性疾病30021.87
    脑卒中22016.03
    贫血14610.64
    呼吸系统疾病1259.11
    低蛋白血症805.83
    肾脏疾病523.79
    消化系统疾病664.81
    静脉性疾病221.60
    下载: 导出CSV

    Table  3.   1 372例糖尿病相关慢性难愈性创面成年住院患者的创面特征

    创面特征例数/个数比例(%)
    形成原因(例)
    感染93067.78
    压力性损伤18713.63
    创伤805.83
    手术644.66
    瘢痕614.45
    其他503.64
    创面类型(例)
    糖尿病足溃疡80958.97
    压力性损伤18713.63
    创伤性溃疡14410.57
    其他23216.83
    创面部位(个)
    足部80945.09
    小腿47426.42
    躯干25214.05
    上肢1337.41
    头面颈部341.90
    大腿341.90
    骶尾部261.45
    臀部211.17
    会阴部110.61
    创面数量(例)
    1个99772.67
    2个及以上37527.33
    注:其他创面形成原因包括肿瘤、静脉淤积等;其他创面类型包括术后切口愈合不良、瘢痕溃疡等
    下载: 导出CSV

    Table  4.   1 372例糖尿病相关慢性难愈性创面成年住院患者的创面分泌物标本病原微生物培养结果

    病原微生物株数比例(%)
    革兰阳性菌23238.28
    金黄色葡萄球菌12520.63
    粪肠球菌508.25
    无乳链球菌213.47
    棒状杆菌152.48
    停乳链球菌101.65
    血液链球菌81.32
    表皮葡萄球菌30.50
    革兰阴性菌32451.49
    铜绿假单胞菌7111.72
    大肠埃希菌7111.72
    肺炎克雷伯菌6110.07
    奇异变形杆菌498.09
    阴沟肠杆菌193.14
    摩氏摩根菌142.31
    鲍曼不动杆菌101.65
    粘质沙雷菌101.65
    普通变形杆菌91.49
    产气肠杆菌81.32
    嗜麦芽窄食单胞菌20.33
    真菌376.11
    其他132.15
    合计606100
    注:其他病原微生物包括厌氧菌及采用常规方法未能鉴定到种的菌株等
    下载: 导出CSV

    Table  5.   1 372例糖尿病相关慢性难愈性创面成年住院患者的创面治疗方式

    治疗方式例数比例(%)
    单纯清创39628.86
    清创+VSD44432.36
    清创+骨水泥13810.06
    清创+VSD+皮片移植866.27
    清创+截肢或截趾术856.20
    清创+VSD+皮瓣移植80.58
    单纯换药15511.30
    其他604.37
    注:VSD为负压封闭引流;其他治疗方式包括人工真皮移植、骨膜牵张等
    下载: 导出CSV

    Table  6.   1 372例糖尿病相关慢性难愈性创面成年住院患者的住院时间及住院费用

    住院时间与住院费用例数比例(%)
    住院时间(d)
    ≤729121.21
    8~1439929.08
    15~2126819.53
    ≥2241430.17
    住院费用(万元)
    <271351.97
    2~<434024.78
    4~<617412.68
    ≥614510.57
    下载: 导出CSV

    Table  7.   不同类型糖尿病相关慢性难愈性创面成年住院患者的住院时间和住院费用及创面愈合情况比较

    创面类型例数住院时间[d,MQ1,Q3)]住院费用[万元,MQ1,Q3)]好转率+愈合率[例(%)]
    糖尿病足溃疡80918(10,29)3.9(2.1,6.0)770 (95.18)
    压力性损伤18714(7,21)a2.8(1.5,4.2)a183(97.86%)
    创伤性溃疡14412(6,18)a2.3(1.2,3.5)a140( 97.22%)
    其他23216(8,25)a3.1(1.8,5.0)a223( 96.12%)
    统计量值H=45.23H=52.67χ2=3.58
    P<0.001<0.0010.310
    注:其他创面包括术后切口愈合不良、瘢痕溃疡等;与糖尿病足溃疡比较,aP<0.05
    下载: 导出CSV
  • 加载中
图(1) / 表(7)
计量
  • 文章访问数:  10
  • HTML全文浏览量:  8
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-06-06
  • 网络出版日期:  2026-03-09

目录

    /

    返回文章
    返回